256amongthevariouscancercelllinesmayrevealtheprecisemolecularmechanismsforcryptotanshinoneaction.
Oneofthemostsalientlimitationstotheclinicalapplicationofanti-canceragentsistheacquiredorintrinsicdrugresistanceevidencedbycertaintumors[29,38–40].Toovercomethislimitation,acombinationtherapywiththecurrentlyusedanti-canceragentshasbeenbroadlyattempted,andwealsoattemptedtodeterminewhethercryptotanshinonecansensitizeHepG2cellsandMCF7cellstovariouscanceragentsincludingFas(APO1/CD95),TNFa,cisplatin,etoposideand5-FU.Infact,adramaticsynergisticeffectoncellapoptosiswasnotedwhencellswereexposedtoacombinationwithcryptotanshinoneandeachanti-cancerreagentwithasigni cantinductionofERstressmarkers(Fig.6).Itwasalsoreportedthatcrypto-tanshinonesigni cantlyenhancesTNFa-inducedapoptosisinKBM-5cells[41]andFas(Apo1/CD95)-mediatedapoptosisinDU145cells[42].Collectively,ourcurrentdatawiththepreviousreportsupportthenotionthatcryptotanshinoneisapotentialanti-canceragent.
AcknowledgmentsThisworkwassupportedbytheNationalResearchFoundationofKorea(NRF)grantfundedbytheKoreagovernment(MEST)(No.2011-0030722).Con ictofinterest
Nocon ictofinterestisdeclared.
References
1.GorlachA,KlappaP,KietzmannT(2006)Theendoplasmicreticulum:folding,calciumhomeostasis,signaling,andredoxcontrol.AntioxidRedoxSignal8:1391–1418
2.BrostromMA,BrostromCO(2003)Calciumdynamicsandendoplasmicreticularfunctionintheregulationofproteinsyn-thesis:implicationsforcellgrowthandadaptability.CellCalcium34:345–363
3.HosoiT,OzawaK(2010)Endoplasmicreticulumstressindis-ease:mechanismsandtherapeuticopportunities.ClinSciLond118:19–29
4.KozutsumiY,SegalM,NormingtonK,GethingMJ,SambrookJ(1988)Thepresenceofmalfoldedproteinsintheendoplasmicreticulumsignalstheinductionofglucose-regulatedproteins.Nature332:462–464
5.ShoreGC,PapaFR,OakesSA(2011)Signalingcelldeathfromtheendoplasmicreticulumstressresponse.CurrOpinCellBiol23:143–149
6.BreckenridgeDG,GermainM,MathaiJP,NguyenM,ShoreGC(2003)Regulationofapoptosisbyendoplasmicreticulumpath-ways.Oncogene22:8608–8618
7.HerrI,DebatinKM(2001)Cellularstressresponseandapoptosisincancertherapy.Blood98:2603–2614
8.KimI,ShuCW,XuWetal(2009)Chemicalbiologyinvesti-gationofcelldeathpathwaysactivatedbyendoplasmicreticulumstressrevealscytoprotectivemodulatorsofASK1.JBiolChem284:1593–1603
9.SzegezdiE,LogueSE,GormanAM,SamaliA(2006)Mediatorsofendoplasmicreticulumstress-inducedapoptosis.EMBORep7:880–885
123
Apoptosis(2012)17:248–257
10.LiJ,LeeB,LeeAS(2006)Endoplasmicreticulumstress-induced
apoptosis:multiplepathwaysandactivationofp53-up-regulatedmodulatorofapoptosis(PUMA)andNOXAbyp53.JBiolChem281:7260–7270
11.SalazarM,CarracedoA,SalanuevaIJetal(2009)Cannabinoid
actioninducesautophagy-mediatedcelldeaththroughstimulationofERstressinhumangliomacells.JClinInvest119:1359–137212.ArmstrongJL,FlockhartR,VealGJ,LovatPE,RedfernCP
(2010)Regulationofendoplasmicreticulumstress-inducedcelldeathbyATF4inneuroectodermaltumorcells.JBiolChem285:6091–6100
13.HealySJ,GormanAM,Mousavi-ShafaeiP,GuptaS,SamaliA
(2009)Targetingtheendoplasmicreticulum-stressresponseasananticancerstrategy.EurJPharmacol625:234–246
14.JinDZ,YinLL,JiXQ,ZhuXZ(2006)Cryptotanshinoneinhibits
cyclooxygenase-2enzymeactivitybutnotitsexpression.EurJPharmacol549:166–172
15.KimEJ,JungSN,SonKHetal(2007)Antidiabetesandanti-obesityeffectofcryptotanshinoneviaactivationofAMP-acti-vatedproteinkinase.MolPharmacol72:62–72
16.MosaddikMA(2003)Invitrocytotoxicityoftanshinonesisolated
fromSalviamiltiorrhizaBungeagainstP388lymphocyticleu-kemiacells.Phytomedicine10:682–685
17.SuhSJ,JinUH,ChoiHJetal(2006)Cryptotanshinonefrom
SalviamiltiorrhizaBUNGEhasaninhibitoryeffectonTNF-alpha-inducedmatrixmetalloproteinase-9productionandHASMCmigrationviadown-regulatedNF-kappaBandAP-1.BiochemPharmacol72:1680–1689
18.DatNT,JinX,LeeJHetal(2007)Abietanediterpenesfrom
Salviamiltiorrhizainhibittheactivationofhypoxia-induciblefactor-1.JNatProd70:1093–1097
19.ShinDS,KimHN,ShinKDetal(2009)Cryptotanshinone
inhibitsconstitutivesignaltransducerandactivatoroftranscrip-tion3functionthroughblockingthedimerizationinDU145prostatecancercells.CancerRes69:193–202
20.LeeWY,LiuKW,YeungJH(2009)Reactiveoxygenspecies-mediatedkinaseactivationbydihydrotanshinoneintanshinones-inducedapoptosisinHepG2cells.CancerLett285:46–57
21.YeY,XuW,ZhongW(2010)Effectsofcryptotanshinoneon
proliferationandapoptosisofHeLacelllineofcervicalcancer.ZhongguoZhongYaoZaZhi35:118–121
22.ChenW,LuoY,LiuLetal(2010)Cryptotanshinoneinhibits
cancercellproliferationbysuppressingMammaliantargetofrapamycin-mediatedcyclinD1expressionandRbphosphoryla-tion.CancerPrevResPhila3:1015–1025
23.HurJM,ShimJS,JungHJ,KwonHJ(2005)Cryptotanshinone
butnottanshinoneIIAinhibitsangiogenesisinvitro.ExpMolMed37:133–137
24.NagaiH,NoguchiT,TakedaK,IchijoH(2007)Pathophysio-logicalrolesofASK1-MAPkinasesignalingpathways.JBio-chemMolBiol40:1–6
25.SekineY,TakedaK,IchijoH(2006)TheASK1-MAPkinase
signalinginERstressandneurodegenerativediseases.CurrMolMed6:87–97
26.IndranIR,TufoG,PervaizS,BrennerC(2011)Recentadvances
inapoptosis,mitochondriaanddrugresistanceincancercells.BiochimBiophysActa1807:735–745
27.IgneyFH,KrammerPH(2002)Deathandanti-death:tumour
resistancetoapoptosis.NatRevCancer2:277–288
28.SrivastavaRK,SasakiCY,HardwickJM,LongoDL(1999)Bcl-2-mediateddrugresistance:inhibitionofapoptosisbyblockingnuclearfactorofactivatedTlymphocytes(NFAT)-inducedFasligandtranscription.JExpMed190:253–265
29.KawaharaA,KobayashiT,NagataS(1998)InhibitionofFas-inducedapoptosisbyBcl-2.Oncogene17:2549–2554
热门文档